Your search for dabigatran returned 6 results

Dabigatran Etexilate Capsules is a direct thrombin inhibitor indicated to reduce the risk of stroke and blood clots.

Significant reductions were seen in dementia risk for rivaroxaban, apixaban, and dabigatran versus warfarin in network meta-analysis

The summary below gives an overview of important additions and changes MPR has made to its drug database through the end of June. The chart below provides highlights of key monograph updates made this month (not an inclusive list). Click on the name of the drugs to view the full monographs on eMPR.com. Key: D=Dosing,…

Dabigatran etexilate mesylate 20mg, 30mg, 40mg, 50mg, 110mg, 150mg; per packet.

Dabigatran etexilate mesylate 75mg, 110mg, 150mg; caps.

No substantial differences seen for other outcomes or for other direct oral anticoagulant comparisons